Understanding The Clinical Research Organization and The Business of Falsifying Bioequivalence
Executive Summary Falsifying bioequivalence is commonly done by what is called clinical research organizations or CROs. Introduction A significant issue with falsifying bioequivalence is the companies paid to prove rather than test bioequivalence. These are called Clinical Research Organizations or CROs. Wait One Second… Why is The Article Not Viewable? You are seeing this text…